This carefully curated thread will give you key insights into my journey and how you can make this transition, seamlessly.
(2 / 14)
Here's how I got started with my first machine learning project and you can too.
— Pratham Prasoon (@PrasoonPratham) December 4, 2020
Let's take a look.
(This thread will take from zero to being a hero in machine learning, trust me)
(1 / 22)
\U0001f9f5\U0001f447 pic.twitter.com/TBDki9Iy7e
Are you planning to learn Python for machine learning this year?
— Pratham Prasoon (@PrasoonPratham) February 13, 2021
Here's everything you need to get started.
\U0001f9f5\U0001f447
SUMMARY: the Oxford/Astra trial examined dosing with gaps between 4-12 wks- although longer gaps appear to be limited mostly to younger participants. There was no difference reported in published data between these & efficacy from the 1st dose seems high for severe disease.
— Deepti Gurdasani (@dgurdasani1) December 31, 2020
Discussions of 1 vs 2 doses suggest many are not aware of Pfizer's trials which evaluated 1 vs 2 dose immunogenicity, assessed multiple formulations (BNT162b1 BNT162b2 etc) & conducted dose-ranging in both young & old adults at the start. Saw "clear benefit of booster at day 21" pic.twitter.com/mpyxu9xFSF
— Dr Nicole E Basta (@IDEpiPhD) December 31, 2020